baber/WOPTO huggingface dataset:
Patent NZ-227487-A (NZ)
Title: Preparation of particle boards using an aminoplast resin characterised in that 2-ureido-4,6-diamino-triazine-1,3,5 and melamine are added to the aminoplast resin
Inventor: BARTHOMIEUX J
IPC: B27N1/02
Filed: 1988-12-22
Abstract: Process for the manufacture of aminoplastic resins according to which 2-ureido-4,6-diamino-1,3,5-triazine and optionally melamine are added to the amino plastic resin. Process according to which the quantity of 2-ureido-4,6-diamino-1,3,5-triazine does not exceed 10% by weight. Application to the manufacture of particle boards.
Patent NZ-244521-A (NZ)
Title: Crystalline etoposide-4'-phosphate diethanolate and its production. (51)
Inventor: FAVREAU DENIS
IPC: A61K31/70
Filed: 1992-09-28
Abstract: The present invention provides temperature stable crystalline etoposide 4'-phosphate diethanol solvate, and a process for its preparation.
Patent NZ-248405-A (NZ)
Title: Double glazing unit with secondary peripheral seal and primary seals with minimum 0.4mm thickness and weight of at least 7g of sealant per side per metre length of spacer frame
Inventor: EVASON JOHN
IPC: E06B3/663
Filed: 1993-08-13
Abstract: A sealed insulating unit comprising two parallel opposed panes (18,19) with a spacing and sealing system therebetween defining, with said panes, a sealed gas spaced between them, said spacing and sealing system comprising a spacer frame (1) with a primary seal (16,17) between each side of the spacer frame and the opposing pane face and a secondary seal (21) extending between the panes outside the outer peripheral face of the spacer frame characterised in that each primary seal is greater than 0.4 mm thick on construction of the unit and comprises at least 7 grams of sealant material on each side of the spacer frame per metre of the spacer frame length. There is also provided a method of producing a sealed insulating unit comprising providing a spacer frame of required size, applying primary sealant to each side face of the spacer frame, assembling the spacer frame with and between two opposed parallel panes so that the spacer frame with the panes defines a gas space therebetween, and, with a primary seal thickness of greater than 0.4 mm on each side of the spacer frame, applying a secondary sealant into a channel between the panes outside the outer peripheral face of the spacer frame and curing said secondary sealant in situ between the panes. There is further provided a spacer for a sealed insulating unit in which in the side walls of the spacer are defined elongate recesses, the dimensions of the recesses being selected such that sufficient primary sealant can be accomodated therein to provide in the sealed insulating unit opposed primary seals each at least 0.4 mm thick. <IMAGE>
Patent NZ-263185-A (NZ)
Title: Use of fungi to reduce the pitch content of pulpwood
Inventor: BLANCHETTE ROBERT A
IPC: C12P1/02
Filed: 1994-03-17
Abstract: The fungi Schizophyllum commune, Trichaptum biforme and Phanerochaete gigantea are useful in reducing the pitch content of pulps and pulpwoods used in making cellulosic products.
Patent NZ-264185-A (NZ)
Title: Luer needle unit having luer needle, supporting cap and syringe cap
Inventor: KATAYAMA HITOSHI
IPC: A61M5/34
Filed: 1994-08-05
Abstract: A luer needle unit and an injector effectively prevent a user's fingers from being hurt when a disposable needle (1) is separated from the luer needle (2) after the use, while realizing simple and positive attachment of the luer needle (2) to a supporting cap (4). Guide protrusions and guide recesses are provided between the luer needle (2) and the supporting cap (4) to prevent the rotation thereof. Guiding projecting portions are formed in the supporting cap (4) to guide a needle part (3) of the luer needle (2) in the axial direction. <IMAGE>
Patent NZ-264487-A (NZ)
Title: Tetracycline based prodrug conjugate, pharmaceutical compositions thereof
Inventor: BOSSLET KLAUS
IPC: A61K47/48
Filed: 1994-09-20
Abstract: Substrate-spacer-prodrug compounds (pro-prodrugs) suited for site specific delivery of drugs, a process of preparing them and their use are described.
Patent NZ-268476-A (NZ)
Title: 14-substituted marcfortines, preparation and pharmaceutical compositions thereof
Inventor: LEE BYUNG H
IPC: A61P33/10
Filed: 1994-06-07
Abstract: There are disclosed 14 alpha -hydroxymarcfortine derivatives of the natural products marcfortine A, B, C, and D useful in the treatment and prevention of helminth and arthropod infections of animals and plants. The synthetic derivatives are of Formula (I).
Patent NZ-281998-A (NZ)
Title: Plant material preservation; method comprising immersion in an aqueous solution of one or more dihydric alcohols having three to six carbon atoms
Inventor: CARSTAIRS MARGARET LOUISE
IPC: A01N3/00
Filed: 1995-03-16
Abstract: PCT No. PCT/GB95/00569 Sec. 371 Date Oct. 9, 1996 Sec. 102(e) Date Oct. 9, 1996 PCT Filed Mar. 16, 1995 PCT Pub. No. WO95/24828 PCT Pub. Date Sep. 21, 1995The invention provides a method of making preserved plant material having the color and texture of fresh plant material and substantially free from curling or distortion, the method comprising the step of immersing the plant material in an aqueous solution comprising from 40% to 95% by weight of one or more C3-C6 dihydric alcohols at a temperature of from 60 DEG  C. to 95 DEG  C. The dihydric alcohols preferably comprise a major fraction of propylene glycol. The immersion is preferably carried out for from 5 to 90 minutes at a temperature of from 65 DEG  to 85 DEG  C. The aqueous solution may also contain dehydrating alcohols and/or polyethylene glycol. The aqueous solution of the dihydric alcohols exchanges for aqueous sap and juices in the plant material, e.g. cut green foliage or cut flowers, without changing the color or texture of the material.
Patent NZ-285155-A (NZ)
Title: Piperazino derivatives of dihydropyridine as bradykinin antagonists, pharmaceutical compositions
Inventor: ITO FUMITAKA
IPC: C07D409/06
Filed: 1997-02-24
Abstract: PCT No. PCT/IB95/00400 Sec. 371 Date Jul. 1, 1997 Sec. 102(e) Date Jul. 1, 1997 PCT Filed May 26, 1995 PCT Pub. No. WO96/06082 PCT Pub. Date Feb. 29, 1996Compound of formula (1) and their pharmaceutically acceptable salts wherein A1,A2,R1, R2,R3,R4,X are as defined in the specification have excellent bradykinin antagonistic activity.    <IMAGE>  (I)
Patent NZ-296340-A (NZ)
Title: Digital identification and authentication of documents by creating repository of hash values based on documents
Inventor: HABER STUART A
IPC: G06F21/64
Filed: 1995-10-25
Abstract: method of validation of a digital document, and for providing a time stamp for such a document uses the following steps:  a)	transmitting a first request for registering a digital document, the request including a representation of the digital document; b)	receiving the first request along with other registration requests; c)	the first request is combined with at least one other request to from a first value; d)	the first value is hashed to generate a first hash value, and a repository of hash values including the first value, the repository depending on the first request and the other requests; e)	the repository is secured by publishing an item in the repository, the item determined at least in part by a request; f)	a location pointer in the repository is created for the first digital document; and g)	a self-verifying name is assigned to the digital document using the location pointer.
Patent NZ-310344-A (NZ)
Title: Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders
Inventor: MUELLER ALAN L
IPC: A61K31/295
Filed: 1996-06-07
Abstract: Compounds 54 to 73, 75 to 79, 81 to 98, 100 to 103, 105 to 109, 111, 114 to 139, 141 to 150 as depicted are used in the manufacture of a medicament for treating neurological disease or disorders. A compound of formula I or a pharmaceutically acceptable salt or complex thereof is also used in the manufacture of a medicament for treating neurological disease or disorders. In formula (I): each X is independently Br, Cl, F, I, CF3, alkyl, OH, O-alkyl or O-acyl; each R1 is independently H, alkyl or O-acyl; each R2 is independently H, alkyl or hydroxyalkyl or both R2's together are imino; R3 is H, methyl or ethyl; R is phenoxy optionally substituted with F, Cl, Br, I, CF3, alkyl, OH, OCF3, O-alkyl or O-acyl and m is 1 to 5 provided that: i) when X is para-fluoro, R4 is not meta-CF3 substituted phenoxy; ii) when X is H then R4 is substituted with meta fluoro, meta-chloro, meta-methyl, ortho-methyl, ortho-fluoro, ortho-chloro, ortho-OH or meta-OH.
Patent NZ-329444-A (NZ)
Title: Indicating changes in the resistance of a living body
Inventor: HUBBARD L RON
IPC: H04H1/00
Filed: 1997-03-24
Abstract: A device for indicating changes in the resistance of a living body includes a resistance measuring circuit 20 having external leads.  The resistance measuring circuit produces a measured signal corresponding to the resistance measured in respective low and high ranges of variable resistances across a living body.  An amplifier circuit 30 amplifies the measured signal to a perceptible level, and an indicator circuit 24 presents the amplified signal in a perceptible form.  Sensitivity adjustment circuitry 28 is connected to the amplifier and indicator circuits for automatically increasing the sensitivity of the indicator circuit when a high variable resistance setting in the second range is measured in the resistance measuring circuit.
Patent NZ-331237-A (NZ)
Title: Superficial chemical skin peels using salicyclic acid
Inventor: KLIGMAN ALBERT M
IPC: A61K8/368
Filed: 1997-02-05
Abstract: A composition comprising at least 15wt.% salicylic acid and a solvent selected from the group of ethanol, isopropanol, methanol, acetone, diethyl ether and propylene glycol, is applied to skin to effect a superficial chemical skin peel.  The skin is wiped with water no later than one hour after the solution has been applied to remove residual applied solution. The composition and method can be used to treat skin affected with a skin disorder such as photodamaged skin, hyperpigmentation, acne vulgaris, rosacea, premalignant skin cancer, wrinkles and superficial scarring.
Patent NZ-331918-A (NZ)
Title: Composition with thickening or gelling agents containing both siloxane groups and hydrogen-bonding groups to thicken compositions containing silicone fluids, these compositions are made into cosmetics by adding an antiperspirant
Inventor: MENDOLIA MICHAEL S
IPC: A61K8/895
Filed: 1997-03-28
Abstract: A base composition suitable for use in forming a cosmetic composition wherein the base composition comprises: a) at least one silicone fluid b) at least one gelling agent in a type to thicken the silicon fluid where the gelling agent is selected from the group consisting of polymers which: 1) contain both siloxane groups and hydrogen bonding groups to thicken compositions containing volatile and/or non-volatile silicone fluids, wherein(I) each segment of siloxane units in the polymer contains an average of 1-1000 siloxane units and(ii)  the hydrogen bonding units are selected from the group consisting of ester groups, urethane groups, urea groups, thoiurea groups, amide groups and combinations thereof; 2) are non flowable at room temperature 3) dissolve in a fluid which contains silicone which fluid is at a temperature of 25-250 degrees C to form a translucent or clear solution at a temperature in this range of 25-250 degrees C.
Patent NZ-335031-A (NZ)
Title: Cellulase with truncated E5 obtained from Thermomonospora fusca for use in laundry processes, to aid in animal feed digestion
Inventor: CLARKSON KATHLEEN A
IPC: A23K1/165
Filed: 1997-09-24
Abstract: A method for treating cellulosic materials are disclosed which comprises contacting the cellulosic material with a cellulase obtained from Thermomonospora fusca corresponding to E5 or a derivative thereof, wherein the contact takes place at a pH greater than 7 but less than 10. Particularly preferred methods comprise stonewashing and detergent cleaning of cotton fabrics, the production of paper products, as an additive to animal feed and in the production of food, starch, ethanol and sugar.
Patent NZ-500507-A (NZ)
Title: Production of an amidated peptide through the use of a fusion protein and release from the fusion protein using an acyl-acceptor
Inventor: COTTINGHAM IAN ROBERT
IPC: H04L12/28
Filed: 1998-05-01
Abstract: A method for the production of a peptide of 3 to 100 amino acids, which comprises the step of expressing the peptide as part of a fusion protein, followed by release of the peptide from the fusion protein by an acyl-acceptor.
Patent NZ-503086-A (NZ)
Title: An orally administrable pharmaceutical composition comprising an inner core and two outer layers, which render it substantially free of unpleasant tastes
Inventor: WALTER GERALD A
IPC: A61K9/42
Filed: 1998-08-22
Abstract: A pharmaceutical composition that is substantially free of unpleasant tastes and orally administrable is described.  It comprises: (a) an active medicament, (b) an inner coating layer comprising an oil substance having a melting point in the range 50-100 oC, (c) an outer coating layer comprising a polymeric substance. The active medicament and the inner coating layer form the inner core, the active medicament is about 5-65% by weight of the total inner care, the oil substance is about 35-95% by weight of the total inner core and the polymeric substance is about 4-90% by weight of the total composition. The oil substance can be chosen from soybean oil, avocado oil, squalene oil, sesame oil, olive oil, canola oil, corn oil, rapeseed oil, safflower oil, sunflower oil, fish oils, flavoured oils, water insoluble vitamins and a polyethylene glycol polymer having a melting point at least above 500 oC or mixtures thereof.
Patent NZ-507865-A (NZ)
Title: Compositions for the preservation of living biological materials comprising trimethyl amine oxide, sodium chloride and calcium ions
Inventor: WIGGINS PHILIPPA M
IPC: C12N1/04
Filed: 1998-04-15
Abstract: A solution for preserving living biological materials that comprises trimethyl amine oxide, sodium chloride, present at a concentration of about 30mM to 65mM, and calcium ions is described.  The solution is to be isotonic with the material to be preserved and is substantially free of iodide, dihydrogen phosphate, bicarbonate, nitrate and bisulfate.  Contacting the biological material with the solution and then maintaining the material at a temperature less than about 4oC preserves the viability of the biological material.
Patent NZ-512376-A (NZ)
Title: Method for manufacturing a package with a peelable zone
Inventor: BOIS HENRI GEORGES
IPC: B31B19/90
Filed: 1999-12-21
Abstract: Packaging formed from a film-like material 10 that has at least one pealable zone is produced by placing strips or edged sections 20 of the peelable material on to the film and flattening the end sections of the material such that it is secured to the film. Also included is a machine for manufacturing packaging with a pealable zone.
Patent NZ-512491-A (NZ)
Title: Thixotropic wood binder compositions
Inventor: ROSTHAUSER JAMES W
IPC: C08L97/02
Filed: 1999-12-18
Abstract: A process for producing wood composite material by combing wood particles with a thixotropic binder composition.  Said binder composition comprises a polymethylene poly(phenyl isocyanate) and a thixotropic agent having a viscosity of less than 1000cps at high shear.
Patent NZ-515194-A (NZ)
Title: Silicon chip token and method for making same
Inventor: CHARLIER GERARD
IPC: G06K19/077
Filed: 2001-01-31
Abstract: Token 10' has a thermoplastic body 12' with upper  and lower  parallel  surfaces 13' and 14', and  has  cavity  15' receiving  a silicon chip identification device 16'.  Cavity 15'  ahs  front opening 17' wherein a solid-state deformable plastic  plug  or  lid 19' is inserted.  The  plug  is  then inserted  and  welded  to the wall  of  cavity  15'  with  a combination of heat and pressure so as to close  the  cavity and    completely   incorporate   the   device   16'.    The identification  device  is capable of communicating  without contact by RF waves with a reading station.
Patent NZ-526268-A (NZ)
Title: Chemical-containing formed material of type of heating of whole the material, container for holding chemical- containing formed material, device for heating and transpiring chemical and indicator for chemical to be heated and vaporized
Inventor: YAMASAKI SATOSHI
IPC: A61L9/02
Filed: 2001-09-06
Abstract: Disclosed herein is a formed material containing a chemical for vaporizing the chemical over a long time through heating it, wherein the whole material is heated, and has a thickness of 3 mm or more, characterized in that it exhibits a heat loss percentage L (L = (h - t)/h X 100, wherein h and t represent a heating temperature and the lowest temperature of the formed material, respectively) of 70 % or less; a container for holding the formed material; an indicator suitable for showing the degree of consumption of the chemical in the material; and a device for heating and transpiring a chemical, which is suitable for heating the formed material. The container has one or more holes for passage of vapor and has a distance between its inner face and the surface of the formed material of 1 to 10 mm. The indicator has a mark that disappears gradually with the elapse of heating time and a mark that appears gradually with heating time. The device has a heating element having a heat generating surface arranged so as to form an angle of 0 to 70 degree to a plane on which the device is placed.
Patent NZ-526943-A (NZ)
Title: Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders
Inventor: RUBIN PAUL D
IPC: A61P11/06
Filed: 1999-06-10
Abstract: The use of a therapeutically effective amount of (+) norcisapride, or a pharmaceutically acceptable salt thereof, substantially free of its (-) stereoisomer, for the manufacture of a medicament for treating apnea or apnea disorders in a patient is disclosed.
Patent NZ-528300-A (NZ)
Title: Irradiating in vivo a body part containing diseased tissue with light having an excitation wavelength between 401 nm to 500 nm
Inventor: LUIKEN GEORGE
IPC: A61B10/00
Filed: 2002-04-04
Abstract: Methods are provided for in vivo detection of diseased tissue in a subject, such as tumor tissue located in a body opening, by administering to the subject a biologically compatible fluorescing targeting construct that binds to or is specifically taken up by the diseased tissue. The observer directly views fluorescence emanating from the fluorescing targeting construct bound to or taken up by the diseased tissue upon irradiation of the targeting construct with excitation light having at least one wavelength in the range from 401 nm to about 495 nm, but preferably lacking light having a wavelength above about 500 nm, so as to determine the location and/or surface area of the diseased tissue in the subject. Since excitation wavelength does not penetrate through tissue, as is the practice in near IR diagnostics, the diseased or abnormal tissue is exposed to the excitation light either surgically or by means of an endoscopic device. Preferably a filter is used to filter out any wavelengths in the excitation light greater than about 500 nm.
Patent NZ-529974-A (NZ)
Title: Swallow tablet comprising paracetamol
Inventor: GRATTAN TIMOTHY JAMES
IPC: A61K31/167
Filed: 2002-06-03
Abstract: A non-effervescent dosage form intended to be swallowed directly such as a swallow tablet or capsule formulation is described. It comprises a therapeutically effective amount of paracetamol, a pharmaceutically acceptable excipient and an amount of antacid up to 55mg per unit dose. The antacid is sodium bicarbonate or potassium bicarbonate or mixtures thereof in a proportion of 85:15 to 90:10% w/w of sodium bicarbonate to sodium carbonate. Paracetamol is disclosed to be in an amount from 325mg to 1000mg, and at least 90% of it being released within 15 minutes. A proviso explains that the dosage form does not comprise a mixture of paracetamol and citric acid
Patent NZ-532705-A (NZ)
Title: 2-aryl-propionic acids and pharmaceutical compositions containing them
Inventor: ALLEGRETTI MARCELLO
IPC: C07C59/135
Filed: 2002-11-19
Abstract: Disclosed is the use of (R,S)-2-Aryl-propionic acid compounds of formula (I) in inhibiting chemotactic activation of neutrophils (PMN leukocytes) induced by the interaction of Interleukin-8 (IL-8) with CXCR1 and CXCR2 membrane receptors. The acids are used for the prevention and treatment of pathologies deriving from said activation. In particular, the (R) enantiomers of said acids are lacking cyclo-oxygenase inhibition activity and are particularly useful in the treatment of neutrofil-dependent pathologies such as psoriasis, ulcerative colitis, melanoma, chronic obstructive pulmonary disease (COPD),bollous pemphigo, rheumatoid arthritis, idiopathic fibrosis, glomerulonephritis and in the prevention and treatment of damages caused by ischemia and reperfusion.
Patent NZ-535006-A (NZ)
Title: Combining and purifying a combination of arachidonic, eicosapentaenoic and docosahexaenoic acids for an edible formulation
Inventor: BIJL HENDRIK LOUIS
IPC: A23L33/00
Filed: 2001-08-01
Abstract: Described is a process for preparing an oil mixture comprising: (a) combining a crude ARA-containing oil with a crude omega-3 PUFA-containing oil to produce a crude oil mixture; and (b) purifying the crude oil mixture by removing phospholipids, trace metals, pigments, soaps, carbohydrates, proteins, sulphur, sterols, mono- or di-glycerides, saturated triglycerides and/or free fatty acids to produce a purified ARA and omega-3 PUFA containing oil mixture.
Patent NZ-539206-A (NZ)
Title: Apparatus for and methods of stress testing metal components
Inventor: JURY BRENT FELIX
Filed: 2003-09-22
Abstract: A tuning device (23) and an apparatus that incorporates the tuning device (23) for use in testing the integrity of a railway line (30) to obtain an improved test signal, the tuning device (23) including an elongate member (23) adapted to be attachable at one end of the railway line (30) being tested in situ or is attachable to an attachment member (21) coupled to the section (10) of railway line (30), and wherein a vibration signal measuring means (24) is adapted to be secured to the other end of the elongate member (23). The apparatus can include a control means (2), a vibration means (3), the tuning device (23) configured and arranged to be attachable to the railway line (30) and a vibration measuring means (24) is attachable to the railway line (3) to directly vibrate the section (10) of the railway line (30), the control means (2) controlling the frequency of vibration and to receive and process measurements of the amplitude of vibration from the tuning device (23) and the frequency of vibration from the vibration measuring means (24).
Patent NZ-539864-A (NZ)
Title: Use of dihydroimidazolones for the treatment of epilepsy in dogs
Inventor: RUNDFELDT CHRIS
IPC: A61P25/22
Filed: 2003-10-09
Abstract: Disclosed is the use of substituted dihydroimidazolones, particularly [1-(4-Chlorophenyl)-4(4-morpholinyl)-2,5-dihydro-1H-imidazol-2-one] (AWD 131-138) or a physiologically acceptable salt thereof for the treatment of idiopathic epilepsy in dogs.